TheProfitWatch

XNCR - Xencor, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
12.43 1.81 (14.56%) --- --- --- 0.03 (0.24%) 1.52 (12.08%) 0.0 (0.0%) 0.0 (0.0%)

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.41
Diluted EPS:
-0.41
Basic P/E:
-34.7317
Diluted P/E:
-34.7317
RSI(14) 1m:
100.0
VWAP:
14.24
RVol:

Events

Period Kind Movement Occurred At

Related News